Effect of Monosaccharides on Intestinal Barrier Function
ENDO-META
Exploratory Study on the Modulation of Endotoxemia and Metabolic Parameters: Role of Macronutrients
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The aim of the present study is to determine the effect of monosaccharides on intestinal barrier function in healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2017
CompletedFirst Submitted
Initial submission to the registry
March 20, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedApril 17, 2019
April 1, 2019
1.3 years
March 20, 2018
April 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in parameters of intestinal barrier function
Changes in endotoxin plasma levels
1 week
Secondary Outcomes (4)
Changes in blood pressure
1 week
Changes in markers for glucose metabolism
1 week
Changes in blood lipid levels
1 week
Changes in Uric Acid levels
1 week
Study Arms (2)
Monosaccharide 1
EXPERIMENTALParticipants receive standardized meals with a defined amount of monosaccharide 1.
Monosaccharide 2
EXPERIMENTALParticipants receive standardized meals with a defined amount of monosaccharide 2.
Interventions
Participants receive different monosaccharides for a defined number of days.
Eligibility Criteria
You may qualify if:
- BMI \<25 kg/m2
- no kown history of metabolic disorders or fatty liver
You may not qualify if:
- food allergies or intolerances (esp. fructose intolerance and malabsorption)
- renal insufficiency
- chronic disease of the gastrointestinal tract
- taking drugs affecting lipid or glucose metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
March 20, 2018
First Posted
March 29, 2018
Study Start
May 20, 2016
Primary Completion
September 9, 2017
Study Completion
August 1, 2018
Last Updated
April 17, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share